Home » Newsletters » BioWorld

BioWorld

March 31, 2003

View Archived Issues

Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline

On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today) Read More

Regeneron, Novartis Enter $75M Deal For IL-1 Trap Technology

Transgenic Mice Generated With Mutant Phosphorylated Synapse Test Retention Of Spatial Memory

Merck Data On Erbitux Status Appear Positive For ImClone

Acadia Raises $25M Privately To Advance Multiple Programs

Antex Filing For Bankruptcy After BioPort Buyout Fizzles

Procyon Acquiring Pharmacor If It Completes Funding Round

Other News To Note

Correction